|
|
| 11.10 Data as of Apr 17 |  -0.46 / -3.98%Today’s Change | 10.24 Today|||52-Week Range 19.90 | -37.22% Year-to-Date |
| The Supreme Court Will Decide the Fate of a Blockbuster Apr 14 / MotleyFool.com |
| Previous close | 11.56 |
| Today’s open | 11.52 |
| Day’s range | 11.05 - 11.65 |
| Volume | 444,848 |
| Average volume (3 months) | 879,599 |
| Market cap | $550.5M |
| Dividend yield | -- |
| Earnings growth (last year) | -83.62% |
| Earnings growth (this year) | +138.13% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -44.52% |
| P/E ratio | NM |
| Price/Sales | 25.38 |
| Price/Book | 2.04 |
| Today’s change | Today’s % change | |
|---|---|---|
| BCRXBioCryst Pharmaceuti... | 0.00 | 0.00% |
| BLUEbluebird bio Inc | +0.37 | +1.89% |
| KMDAKamada Ltd | +0.17 | +1.15% |
| HPTXHyperion Therapeutic... | -0.26 | -1.04% |
| Next reporting date | May 6, 2014 |
| EPS forecast (this quarter) | -$0.55 |
| Annual revenue (last year) | $35.5M |
| Annual profit (last year) | -$108.4M |
| Net profit margin | -305.68% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Craig A. Wheeler |
Chief Financial Officer, Director & Senior VP Richard P. Shea |
Corporate headquarters Cambridge, Massachusetts |
.
